Comments
Loading...
Sensei Biotherapeutics Insider Trading Activity | NASDAQ:SNSE | Benzinga
Track the latest Sensei Biotherapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Sensei Biotherapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Sensei Biotherapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Sensei Biotherapeutics Inc
Shares Outstanding
25.151M
Insider Shares Owned
5.644M
Insider Percentage Owned
22.4%
Institutional Shares Held
1.243M
Institutional Percentage Held
4.94%
| Sep 13, 2023 | John Celebi | PRESIDENT AND CEO | 500.00 | $0.85 | $425.00 | BUY | 0.45% | 111.31K | Sep 11 | View |
| Jun 02, 2023 | Apeiron Investment Group LtdChristian AngermayerPresight Sensei CoInvest Fund LPPresight CoInvest Management LLC | 10% OWNER | -3.44M | $1.58 | -$5.44M | SELL | -100.00% | 0.00 | Jun 01 | View |
| Feb 27, 2023 | Apeiron Investment Group LtdChristian AngermayerPresight Sensei CoInvest Fund LPPresight CoInvest Management LLC | 10% OWNER | 2.20K | $1.61 | $3.54K | BUY | 0.06% | 3.44M | Feb 23 | View |
| Mar 02, 2022 | Cambrian BioPharma Inc | 10% OWNER | 1.20K | $3.20 | $3.85K | BUY | 0.02% | 5.23M | Mar 02 | View |
| Mar 02, 2022 | James Peyer | DIRECTOR | 1.20K | $3.20 | $3.85K | BUY | 0.02% | 5.23M | Mar 02 | View |
| Mar 01, 2022 | James Peyer | DIRECTOR | 2.50K | $3.60 | $9.00K | BUY | 0.05% | 5.23M | Feb 28 - Mar 01 | View |
| Mar 01, 2022 | Cambrian BioPharma Inc | 10% OWNER | 2.50K | $3.60 | $9.00K | BUY | 0.05% | 5.23M | Feb 28 - Mar 01 | View |
| Feb 28, 2022 | James Peyer | DIRECTOR | 2.50K | $3.65 | $9.13K | BUY | 0.05% | 5.23M | Feb 25 | View |
| Feb 28, 2022 | Cambrian BioPharma Inc | 10% OWNER | 2.50K | $3.65 | $9.13K | BUY | 0.05% | 5.23M | Feb 25 | View |
| Feb 24, 2022 | Cambrian BioPharma Inc | 10% OWNER | 17.50K | $3.65 | $63.95K | BUY | 0.34% | 5.23M | Feb 23 - Feb 24 | View |
| Feb 24, 2022 | James Peyer | DIRECTOR | 17.50K | $3.65 | $63.95K | BUY | 0.34% | 5.23M | Feb 23 - Feb 24 | View |
| Feb 22, 2022 | James Peyer | DIRECTOR | 19.95K | $4.02 | $80.19K | BUY | 0.38% | 5.21M | Feb 17 - Feb 18 | View |
| Feb 22, 2022 | Cambrian BioPharma Inc | 10% OWNER | 19.95K | $4.02 | $80.19K | BUY | 0.38% | 5.21M | Feb 17 - Feb 18 | View |
| Feb 16, 2022 | Cambrian BioPharma Inc | 10% OWNER | 12.55K | $4.19 | $52.64K | BUY | 0.24% | 5.19M | Feb 14 - Feb 16 | View |
| Feb 16, 2022 | James Peyer | DIRECTOR | 12.55K | $4.19 | $52.64K | BUY | 0.24% | 5.19M | Feb 14 - Feb 16 | View |
| Feb 14, 2022 | James Peyer | DIRECTOR | 17.50K | $4.45 | $77.90K | BUY | 0.34% | 5.18M | Feb 10 - Feb 11 | View |
| Feb 14, 2022 | Cambrian BioPharma Inc | 10% OWNER | 17.50K | $4.45 | $77.90K | BUY | 0.34% | 5.18M | Feb 10 - Feb 11 | View |
| Feb 08, 2022 | Cambrian BioPharma Inc | 10% OWNER | 30.00K | $4.53 | $135.80K | BUY | 0.58% | 5.16M | Feb 03 - Feb 08 | View |
| Feb 08, 2022 | James Peyer | DIRECTOR | 30.00K | $4.53 | $135.80K | BUY | 0.58% | 5.16M | Feb 03 - Feb 08 | View |
| Jan 31, 2022 | Cambrian BioPharma Inc | 10% OWNER | 15.00K | $4.26 | $63.85K | BUY | 0.29% | 5.13M | Jan 27 - Jan 28 | View |
| Jan 31, 2022 | James Peyer | DIRECTOR | 15.00K | $4.26 | $63.85K | BUY | 0.29% | 5.13M | Jan 27 - Jan 28 | View |
| Jan 27, 2022 | James Peyer | DIRECTOR | 50.00K | $4.72 | $235.82K | BUY | 0.99% | 5.11M | Jan 25 - Jan 26 | View |
| Jan 27, 2022 | Cambrian BioPharma Inc | 10% OWNER | 50.00K | $4.72 | $235.82K | BUY | 0.99% | 5.11M | Jan 25 - Jan 26 | View |
| Jan 25, 2022 | James Peyer | DIRECTOR | 47.41K | $4.82 | $228.53K | BUY | 0.95% | 5.06M | Jan 21 - Jan 24 | View |
| Jan 25, 2022 | Cambrian BioPharma Inc | 10% OWNER | 47.41K | $4.82 | $228.53K | BUY | 0.95% | 5.06M | Jan 21 - Jan 24 | View |
| Jan 21, 2022 | James Peyer | DIRECTOR | 30.24K | $5.10 | $154.31K | BUY | 0.61% | 5.02M | Jan 19 - Jan 20 | View |
| Jan 21, 2022 | Cambrian BioPharma Inc | 10% OWNER | 30.24K | $5.10 | $154.31K | BUY | 0.61% | 5.02M | Jan 19 - Jan 20 | View |
| Jan 20, 2022 | James Peyer | DIRECTOR | 10.00K | $5.08 | $50.80K | BUY | 0.20% | 4.99M | Jan 18 | View |
| Jan 20, 2022 | Cambrian BioPharma Inc | 10% OWNER | 10.00K | $5.08 | $50.80K | BUY | 0.20% | 4.99M | Jan 18 | View |
| Jan 18, 2022 | James Peyer | DIRECTOR | 26.17K | $5.10 | $133.39K | BUY | 0.53% | 4.98M | Jan 13 - Jan 14 | View |
| Jan 18, 2022 | Cambrian BioPharma Inc | 10% OWNER | 26.17K | $5.10 | $133.39K | BUY | 0.53% | 4.98M | Jan 13 - Jan 14 | View |
| Jan 13, 2022 | James Peyer | DIRECTOR | 20.05K | $5.20 | $104.21K | BUY | 0.41% | 4.95M | Jan 11 - Jan 12 | View |
| Jan 13, 2022 | Cambrian BioPharma Inc | 10% OWNER | 20.05K | $5.20 | $104.21K | BUY | 0.41% | 4.95M | Jan 11 - Jan 12 | View |
| Jan 11, 2022 | James Peyer | DIRECTOR | 10.00K | $5.28 | $52.80K | BUY | 0.20% | 4.93M | Jan 10 | View |
| Jan 11, 2022 | Cambrian BioPharma Inc | 10% OWNER | 10.00K | $5.28 | $52.80K | BUY | 0.20% | 4.93M | Jan 10 | View |
| Jan 03, 2022 | James Peyer | DIRECTOR | 1.13K | $4.85 | $5.47K | BUY | 0.02% | 4.92M | Dec 30 | View |
| Jan 03, 2022 | Cambrian BioPharma Inc | 10% OWNER | 1.13K | $4.85 | $5.47K | BUY | 0.02% | 4.92M | Dec 30 | View |
| Dec 30, 2021 | James Peyer | DIRECTOR | 69.00K | $4.98 | $343.62K | BUY | 1.42% | 4.92M | Dec 29 | View |
| Dec 30, 2021 | Cambrian BioPharma Inc | 10% OWNER | 69.00K | $4.98 | $343.62K | BUY | 1.42% | 4.92M | Dec 29 | View |
| Dec 29, 2021 | James Peyer | DIRECTOR | 11.29K | $5.28 | $59.60K | BUY | 0.23% | 4.85M | Dec 28 | View |
| Dec 29, 2021 | Cambrian BioPharma Inc | 10% OWNER | 11.29K | $5.28 | $59.60K | BUY | 0.23% | 4.85M | Dec 28 | View |
| Dec 27, 2021 | James Peyer | DIRECTOR | 3.71K | $5.30 | $19.67K | BUY | 0.08% | 4.84M | Dec 27 | View |
| Dec 27, 2021 | Cambrian BioPharma Inc | 10% OWNER | 3.71K | $5.30 | $19.67K | BUY | 0.08% | 4.84M | Dec 27 | View |
| Dec 23, 2021 | James Peyer | DIRECTOR | 11.00K | $5.27 | $57.97K | BUY | 0.23% | 4.83M | Dec 23 | View |
| Dec 23, 2021 | Cambrian BioPharma Inc | 10% OWNER | 11.00K | $5.27 | $57.97K | BUY | 0.23% | 4.83M | Dec 23 | View |
| Dec 21, 2021 | James Peyer | DIRECTOR | 117.00 | $5.29 | $618.93 | BUY | 0.00% | 4.82M | Dec 17 | View |
| Dec 21, 2021 | Cambrian BioPharma Inc | 10% OWNER | 117.00 | $5.29 | $618.93 | BUY | 0.00% | 4.82M | Dec 17 | View |
| Dec 20, 2021 | Cambrian BioPharma Inc | 10% OWNER | 10.93K | $5.25 | $57.36K | BUY | 0.23% | 4.82M | Dec 16 | View |
| Dec 20, 2021 | James Peyer | DIRECTOR | 10.93K | $5.25 | $57.36K | BUY | 0.23% | 4.82M | Dec 16 | View |
| Dec 13, 2021 | THOMAS RICKS | DIRECTOR | 40.00K | $6.24 | $249.60K | BUY | 13.26% | 341.77K | Dec 09 - Dec 10 | View |
| Aug 12, 2021 | Hamilton Robert Pierce | CHIEF SCIENTIFIC OFFICER | -16.03K | $7.34 | -$117.72K | SELL | -100.00% | 0.00 | Aug 11 | View |
| Aug 10, 2021 | Hamilton Robert Pierce | CHIEF SCIENTIFIC OFFICER | -79.79K | $7.12 | -$568.25K | SELL | -83.27% | 16.03K | Aug 06 - Aug 10 | View |
| May 06, 2021 | Cambrian BioPharma Inc | 10% OWNER | 350.00 | $12.00 | $4.20K | BUY | 0.01% | 4.81M | May 05 | View |
| May 06, 2021 | James Peyer | DIRECTOR | 350.00 | $12.00 | $4.20K | BUY | 0.01% | 4.81M | May 05 | View |
| Apr 21, 2021 | Cambrian BioPharma Inc | 10% OWNER | 385.00 | $12.77 | $4.92K | BUY | 0.01% | 4.81M | Apr 20 | View |
| Apr 21, 2021 | James Peyer | DIRECTOR | 385.00 | $12.77 | $4.92K | BUY | 0.01% | 4.81M | Apr 20 | View |
| Apr 20, 2021 | James Peyer | DIRECTOR | 1.97K | $13.38 | $26.29K | BUY | 0.04% | 4.81M | Apr 19 | View |
| Apr 20, 2021 | Cambrian BioPharma Inc | 10% OWNER | 1.97K | $13.38 | $26.29K | BUY | 0.04% | 4.81M | Apr 19 | View |
| Apr 14, 2021 | Cambrian BioPharma Inc | 10% OWNER | 2.00K | $14.00 | $28.00K | BUY | 0.04% | 4.81M | Apr 13 | View |
| Apr 14, 2021 | James Peyer | DIRECTOR | 2.00K | $14.00 | $28.00K | BUY | 0.04% | 4.81M | Apr 13 | View |
| Apr 08, 2021 | James Peyer | DIRECTOR | 2.00K | $14.00 | $28.00K | BUY | 0.04% | 4.81M | Apr 07 | View |
| Apr 08, 2021 | Cambrian BioPharma Inc | 10% OWNER | 2.00K | $14.00 | $28.00K | BUY | 0.04% | 4.81M | Apr 07 | View |
| Apr 02, 2021 | Cambrian BioPharma Inc | 10% OWNER | 1.00K | $14.00 | $14.00K | BUY | 0.02% | 4.81M | Apr 01 | View |
| Apr 02, 2021 | James Peyer | DIRECTOR | 1.00K | $14.00 | $14.00K | BUY | 0.02% | 4.81M | Apr 01 | View |
| Mar 31, 2021 | Cambrian BioPharma Inc | 10% OWNER | 2.00K | $12.00 | $24.00K | BUY | 0.04% | 4.80M | Mar 30 | View |
| Mar 31, 2021 | James Peyer | DIRECTOR | 2.00K | $12.00 | $24.00K | BUY | 0.04% | 4.80M | Mar 30 | View |
| Mar 25, 2021 | James Peyer | DIRECTOR | 3.75K | $14.12 | $52.95K | BUY | 0.08% | 4.80M | Mar 24 | View |
| Mar 25, 2021 | Cambrian BioPharma Inc | 10% OWNER | 3.75K | $14.12 | $52.95K | BUY | 0.08% | 4.80M | Mar 24 | View |
| Mar 24, 2021 | James Peyer | DIRECTOR | 10.00K | $14.34 | $143.40K | BUY | 0.21% | 4.80M | Mar 23 | View |
| Mar 24, 2021 | Cambrian BioPharma Inc | 10% OWNER | 10.00K | $14.34 | $143.40K | BUY | 0.21% | 4.80M | Mar 23 | View |
| Mar 23, 2021 | Cambrian BioPharma Inc | 10% OWNER | 2.18K | $15.02 | $32.79K | BUY | 0.05% | 4.79M | Mar 22 | View |
| Mar 23, 2021 | James Peyer | DIRECTOR | 2.18K | $15.02 | $32.79K | BUY | 0.05% | 4.79M | Mar 22 | View |
| Mar 19, 2021 | Cambrian BioPharma Inc | 10% OWNER | 817.00 | $15.25 | $12.46K | BUY | 0.02% | 4.79M | Mar 18 | View |
| Mar 19, 2021 | James Peyer | DIRECTOR | 817.00 | $15.25 | $12.46K | BUY | 0.02% | 4.79M | Mar 18 | View |
| Mar 10, 2021 | James Peyer | DIRECTOR | 1.00K | $15.25 | $15.25K | BUY | 0.02% | 4.79M | Mar 08 | View |
| Mar 10, 2021 | Cambrian BioPharma Inc | 10% OWNER | 1.00K | $15.25 | $15.25K | BUY | 0.02% | 4.79M | Mar 08 | View |
| Mar 08, 2021 | Cambrian BioPharma Inc | 10% OWNER | 8.00K | $13.75 | $110.00K | BUY | 0.17% | 4.78M | Mar 05 | View |
| Mar 08, 2021 | James Peyer | DIRECTOR | 8.00K | $13.75 | $110.00K | BUY | 0.17% | 4.78M | Mar 05 | View |
| Mar 05, 2021 | Cambrian BioPharma Inc | 10% OWNER | 5.00K | $15.16 | $75.80K | BUY | 0.10% | 4.78M | Mar 03 - Mar 04 | View |
| Mar 05, 2021 | James Peyer | DIRECTOR | 5.00K | $15.16 | $75.80K | BUY | 0.10% | 4.78M | Mar 03 - Mar 04 | View |
| Mar 03, 2021 | James Peyer | DIRECTOR | 3.00K | $16.25 | $48.75K | BUY | 0.06% | 4.77M | Mar 02 | View |
| Mar 03, 2021 | Cambrian BioPharma Inc | 10% OWNER | 3.00K | $16.25 | $48.75K | BUY | 0.06% | 4.77M | Mar 02 | View |
| Mar 02, 2021 | James Peyer | DIRECTOR | 5.00K | $16.25 | $81.25K | BUY | 0.10% | 4.77M | Feb 26 | View |
| Mar 02, 2021 | Cambrian BioPharma Inc | 10% OWNER | 5.00K | $16.25 | $81.25K | BUY | 0.10% | 4.77M | Feb 26 | View |
| Feb 26, 2021 | James Peyer | DIRECTOR | 31.00K | $16.48 | $510.86K | BUY | 0.66% | 4.76M | Feb 24 - Feb 25 | View |
| Feb 26, 2021 | Cambrian BioPharma Inc | 10% OWNER | 31.00K | $16.48 | $510.86K | BUY | 0.66% | 4.76M | Feb 24 - Feb 25 | View |
| Feb 25, 2021 | James Peyer | DIRECTOR | 20.30K | $17.79 | $361.07K | BUY | 0.43% | 4.73M | Feb 23 | View |
| Feb 25, 2021 | Cambrian BioPharma Inc | 10% OWNER | 20.30K | $17.79 | $361.07K | BUY | 0.43% | 4.73M | Feb 23 | View |
| Feb 24, 2021 | Cambrian BioPharma Inc | 10% OWNER | 9.80K | $18.88 | $185.06K | BUY | 0.21% | 4.71M | Feb 22 | View |
| Feb 24, 2021 | James Peyer | DIRECTOR | 9.80K | $18.88 | $185.06K | BUY | 0.21% | 4.71M | Feb 22 | View |
| Feb 23, 2021 | James Peyer | DIRECTOR | 11.79K | $19.77 | $233.01K | BUY | 0.25% | 4.70M | Feb 19 | View |
| Feb 23, 2021 | Cambrian BioPharma Inc | 10% OWNER | 11.79K | $19.77 | $233.01K | BUY | 0.25% | 4.70M | Feb 19 | View |
| Feb 19, 2021 | James Peyer | DIRECTOR | 753.00 | $19.75 | $14.87K | BUY | 0.02% | 4.69M | Feb 18 | View |
| Feb 19, 2021 | Cambrian BioPharma Inc | 10% OWNER | 753.00 | $19.75 | $14.87K | BUY | 0.02% | 4.69M | Feb 18 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.